PRACTICAL SYNTHESES OF PHOSPHOINOSITIDES

Information

  • Research Project
  • 3497797
  • ApplicationId
    3497797
  • Core Project Number
    R43GM037351
  • Full Project Number
    1R43GM037351-01
  • Serial Number
    37351
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/1986 - 38 years ago
  • Project End Date
    4/30/1987 - 37 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1986 - 38 years ago
  • Budget End Date
    4/30/1987 - 37 years ago
  • Fiscal Year
    1986
  • Support Year
    1
  • Suffix
  • Award Notice Date
    -
Organizations

PRACTICAL SYNTHESES OF PHOSPHOINOSITIDES

There is a tremendous current and growing interest in the role of membrane phosphoinositides in cell biology, especially in relation to the transmission of Ca2+ mediated signals which are generated when cell-surface receptors are activated by hormones, neurotransmitters, growth factors, and other agonists, in relation to the mechanism of malignant transformations induced by oncogenes, and, the activation of kinase C. Samples of pure phosphoinositides and analogs are important for research and as potential therapeutic agents. Practical methods for their preparation by synthesis are not available. The overall objective of this proposal is to develop a general, simple and practical method for the synthesis of distinct molecular species of phosphatidylinositol (PI), phosphatidylinositol-4-phosphate (PIP), and, phosphatidylinositol-4,5-bisphosphate (PIP2), each carrying fattyacyl residues of choice in positions 1', 2'. The strategy is to replace the mixtures of fattyacyls in natural PI and derivatives with any desired fattyacyls by a deacylation - reacylation cycle, or, by removal and reintroduction of the complete diglyceride residue. The synthesis depends critically on an innovative application of lipases in a composite chemical and enzymatic sequence. During Phase I, this critical aspect, and the pre-requisite protection and deblocking of the inositol hydroxyls will be evaluated for the preparation of semi-synthetic 1',2'-diacyl-sn-glycerophosphoinositols from PI isolated from soylecithin, so as to determine the feasibility of the general strategy.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    BNP
  • Study Section Name
    Bio-Organic and Natural Products Chemistry Study Section
  • Organization Name
    NUTRIMED BIOTECH
  • Organization Department
  • Organization DUNS
  • Organization City
    ITHACA
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    14850
  • Organization District
    UNITED STATES